Select Medical Holdings Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Select Medical Holdings is de winst gegroeid met een gemiddeld jaarlijks percentage van 3.3%, terwijl de Healthcare industrie de winst jaarlijks groeide met 7.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 5.4% per jaar. Het rendement op eigen vermogen van Select Medical Holdings is 15.4%, en het heeft een nettomarge van 3.8%.

Belangrijke informatie

3.3%

Groei van de winst

4.6%

Groei van de winst per aandeel

Healthcare Groei van de industrie	15.7%
Inkomstengroei	5.4%
Rendement op eigen vermogen	15.4%
Nettomarge	3.8%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Opbrengsten en kosten

Hoe Select Medical Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

DB:S24 Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Sep 24	6,969	266	587
30 Jun 24	6,873	259	575
31 Mar 24	6,788	260	562
31 Dec 23	6,664	235	553
30 Sep 23	6,587	217	545
30 Jun 23	6,489	196	537
31 Mar 23	6,399	174	527
31 Dec 22	6,334	153	517
30 Sep 22	6,312	175	509
30 Jun 22	6,278	223	504
31 Mar 22	6,258	329	498
31 Dec 21	6,205	389	491
30 Sep 21	6,105	415	487
30 Jun 21	5,995	415	482
31 Mar 21	5,664	306	477
31 Dec 20	5,532	250	474
30 Sep 20	5,446	206	469
30 Jun 20	5,415	162	626
31 Mar 20	5,544	155	541
31 Dec 19	5,454	143	452
30 Sep 19	5,344	136	674
30 Jun 19	5,218	138	428
31 Mar 19	5,153	140	426
31 Dec 18	5,081	133	426
30 Sep 18	4,911	207	174
30 Jun 18	4,720	193	229
31 Mar 18	4,527	189	286
31 Dec 17	4,365	171	379
30 Sep 17	4,300	93	339
30 Jun 17	4,259	82	340
31 Mar 17	4,237	74	337
31 Dec 16	4,217	112	329
30 Sep 16	4,211	121	321
30 Jun 16	4,178	143	305
31 Mar 16	3,973	146	279
31 Dec 15	3,683	127	257
30 Sep 15	3,420	123	242
30 Jun 15	3,165	121	205
31 Mar 15	3,052	119	219
31 Dec 14	3,020	117	214
30 Sep 14	2,997	121	208
30 Jun 14	2,963	118	225
31 Mar 14	2,949	111	202
31 Dec 13	2,938	112	201

Kwaliteitswinsten: S24 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (3.8%) S24 } zijn hoger dan vorig jaar (3.3%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van S24 is de afgelopen 5 jaar met 3.3% per jaar gegroeid.

Versnelling van de groei: De winstgroei van S24 over het afgelopen jaar ( 22.7% ) overtreft het 5-jarig gemiddelde ( 3.3% per jaar).

Winst versus industrie: De winstgroei S24 over het afgelopen jaar ( 22.7% ) overtrof de Healthcare -sector 40.5%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 15.4% ) van S24 wordt als laag beschouwd.

Select Medical Holdings Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Third quarter 2024 earnings released: EPS: US$0.43 (vs US$0.38 in 3Q 2023)

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: EPS: US$0.60 (vs US$0.61 in 2Q 2023)

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

First quarter 2024 earnings released: EPS: US$0.75 (vs US$0.56 in 1Q 2023)

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Recent updates

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter dividend of US$0.13 announced

Third quarter 2024 earnings released: EPS: US$0.43 (vs US$0.38 in 3Q 2023)

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Revenue and earnings growth

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings released: EPS: US$0.60 (vs US$0.61 in 2Q 2023)

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Investor sentiment improves as stock rises 18%

First quarter dividend of US$0.13 announced

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: US$0.75 (vs US$0.56 in 1Q 2023)

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings released: EPS: US$1.91 (vs US$1.23 in FY 2022)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$0.21 in 3Q 2022)

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Second quarter 2023 earnings released: EPS: US$0.61 (vs US$0.43 in 2Q 2022)

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Insider recently sold €268k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023

First quarter 2023 earnings released: EPS: US$0.56 (vs US$0.37 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.23 (vs US$2.99 in FY 2021)

Select Medical Holdings Corporation to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment improved over the past week

Upcoming dividend of US$0.13 per share

Third quarter 2022 earnings released: EPS: US$0.21 (vs US$0.57 in 3Q 2021)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 29, 2022

Select Medical Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022

Now 21% undervalued

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About September 2, 2022

Now 24% undervalued

Second quarter 2022 earnings released: EPS: US$0.43 (vs US$1.22 in 2Q 2021)

Select Medical Holdings Corporation to Report Q2, 2022 Results on Aug 04, 2022

Upcoming dividend of US$0.13 per share

First quarter 2022 earnings released: EPS: US$0.37 (vs US$0.82 in 1Q 2021)

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or About June 1, 2022

Select Medical Holdings Corporation to Report Q1, 2022 Results on May 05, 2022

Select Medical Holdings Corporation (NYSE:SEM) acquired Six Critical Illness Recovery Hospitals.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Select Medical Holdings Corporation Provides Revenue Guidance for the Year 2022

Investor sentiment deteriorated over the past week

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ended December 31, 2021

Third quarter 2021 earnings released: EPS US$0.57 (vs US$0.57 in 3Q 2020)

Independent Director recently sold €308k worth of stock

Upcoming dividend of US$0.13 per share

Second quarter 2021 earnings released: EPS US$1.22 (vs US$0.39 in 2Q 2020)

Select Medical Holdings Corporation Provides Earnings Outlook for the Full Year 2021

Select Medical Holdings Corporation (NYSE:SEM) completed the acquisition of AcuityHealthcare, LP.

Select Medical Holdings Corporation (NYSE:SEM) and Northwest Healthcare agreed to acquire Curahealth Tucson from Curahealth, LLC.

Independent Director recently sold €349k worth of stock

Insider recently sold €163k worth of stock

Insider recently sold €154k worth of stock